scispace - formally typeset
T

Tanja Ball

Researcher at Medical University of Vienna

Publications -  28
Citations -  1561

Tanja Ball is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Immunoglobulin E & Allergen. The author has an hindex of 20, co-authored 28 publications receiving 1534 citations. Previous affiliations of Tanja Ball include Albert Einstein College of Medicine & Vienna General Hospital.

Papers
More filters
Journal ArticleDOI

The molecular basis for allergen cross-reactivity: crystal structure and IgE-epitope mapping of birch pollen profilin.

Alexander A. Fedorov, +4 more
- 15 Jan 1997 - 
TL;DR: Structural homology indicates that the basic features of the G actin-profilin interaction are conserved in all eukaryotic organisms, but suggests that mechanistic differences in the binding of proline-rich ligands may exist.
Journal ArticleDOI

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.

Tanja Ball, +7 more
- 01 Jun 1999 - 
TL;DR: The finding that immunotherapy induced antibody responses against previously not recognized B cell epitopes indicates the vaccination character of this treatment and emphasizes the need for novel forms of component‐resolved immunotherapy.
Journal ArticleDOI

Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination

Margarete Focke, +7 more
- 01 Sep 2001 - 
TL;DR: It is demonstrated that synthetic hypoallergenic peptides derived from B cell epitopes of major allergens represent safe vaccine candidates for the treatment of IgE‐ mediated allergies.
Journal Article

Immunization with Purified Natural and Recombinant Allergens Induces Mouse IgG1 Antibodies That Recognize Similar Epitopes as Human IgE and Inhibit the Human IgE-Allergen Interaction and Allergen-Induced Basophil Degranulation

Susanne Vrtala, +9 more
- 15 Jun 1998 - 
TL;DR: The data indicate that 1) the allergenic potency of a protein may be related to its overall immunogenicity and 2) prolonged immunization with single purified recombinant allergens induces protective IgG Abs.
Journal ArticleDOI

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.

Rudolf Valenta, +8 more
- 01 Jul 1999 - 
TL;DR: Molecular strategies which have been recently applied to generate genetically engineered and synthetic hypoallergenic allergen derivatives for patient-tailored and safe vaccination against Type I allergy are reviewed.